Windtree Therapeutics
Stock Forecast, Prediction & Price Target
Windtree Therapeutics Financial Estimates
Windtree Therapeutics Revenue Estimates
Windtree Therapeutics EBITDA Estimates
Windtree Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $12.2M Low: $12.2M High: $12.2M avg. 0% | Avg: $12.4M Low: $12.4M High: $12.4M avg. 1.63% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
Net Income
% change YoY
| $-67.63M N/A | $-39.20M 42.03% | $-20.29M 48.24% | Avg: $-29.7M Low: $-46.04M High: $-46.04M avg. -46.37% | Avg: $-35.5M Low: $-42.55M High: $-42.55M avg. -19.52% | Avg: $-43.95M Low: $-43.95M High: $-43.95M avg. -23.81% | Avg: $-2.75M Low: $-2.75M High: $-2.75M avg. 93.73% |
EBITDA
% change YoY
| $-32.48M N/A | $-21.07M 35.12% | $-20.15M 4.35% | Avg: $7.32M Low: $7.32M High: $7.32M avg. 136.31% | Avg: $7.44M Low: $7.44M High: $7.44M avg. 1.63% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$136.64 N/A | -$62.23 54.45% | -$92.23 -48.20% | Avg: -$11.88 Low: -$11.88 High: -$11.88 avg. 87.11% | Avg: -$10.98 Low: -$10.98 High: -$10.98 avg. 7.57% | Avg: -$11.34 Low: -$11.34 High: -$11.34 avg. -3.27% | Avg: -$0.71 Low: -$0.71 High: -$0.71 avg. 93.73% |
Operating Expenses
% change YoY
| $32.26M N/A | $21.88M -32.14% | $17.45M -20.24% | Avg: $162.61M Low: $162.61M High: $162.61M avg. 831.53% | Avg: $165.28M Low: $165.28M High: $165.28M avg. 1.63% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Windtree Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1.00% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -46.04M, average is -29.7M and high is -46.04M.
What is Windtree Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.40% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $12.2M, average is $12.2M and high is $12.2M.
What is Windtree Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 46.28% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$11.88, average is -$11.88 and high is $-11.87.